Oct 10 2023 eGenesis Announces Publication in Nature of Landmark Preclinical Data Demonstrating Long-Term Survival with Genetically Engineered Porcine Kidneys Company
Jun 13 2023 eGenesis Announces Publication in Nature Communications Characterizing Renal Physiology and Endocrine Function in Non-Human Primates Post Xenograft Transplant Company
Jun 05 2023 eGenesis Presents New Data on Long-Term Survival in Preclinical Kidney Xenotransplantation at American Transplant Congress 2023 Kidney
Apr 11 2023 Karius and eGenesis partner to help accelerate xenotransplantation for patients in need of organ transplants Kidney Partnerships
Jan 09 2023 eGenesis and Eledon Pharmaceuticals Announce Collaboration for Use of Tegoprubart in Preclinical Xenotransplantation Studies Company Partnerships
Mar 09 2022 eGenesis Announces Research Collaboration with the University of Miami to Evaluate Human Compatible Islet Cells in Diabetes Model Company Partnerships
Jun 08 2021 eGenesis Appoints Bradford Smith as an Independent Member of Its Board of Directors Company
Apr 01 2021 eGenesis Expands Research Collaboration with Leading Academic Medical Center Kidney Partnerships
Mar 03 2021 eGenesis Appoints Financial Executive, Sapna Srivastava, Ph.D., as Chief Financial Officer Company
